ViroCyt white paper: Exhibitors of the World Vaccine Congress, Washington, 2015

Guest blog: ViroCyt ‘Virotherapy Process Optimization’ white paper

An emerging application of viruses involves engineering them to treat diseases using a number of approaches. Broadly defined under the “Virotherapy” umbrella, these include viral vectors used for gene therapy, oncolytic viruses and viral immunotherapy. A significant challenge, as it is for any virus-based technology, is gaining a clear picture of the quality of a sample at any given point: …

White Paper provided by Virocyt: An Overview of Virus Quantification Techniques

Click here to download the White Paper provided by Virocyt: “An Overview of Virus Quantification Techniques”. Settings in which viruses play a primary role, such as vaccine production, using viruses to express proteins, the development of antiviral drugs, and therapeutic viruses (oncolytic viruses for example), require accurate assessment of viral concentration across the entire product development lifecycle.  Although time-tested, many …